CerMed International has received CE mark approval for its CerMap cervical specimen collection device.
CerMap provides a technique for collecting cervical cells, used in cervical cancer screening procedures.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The approval allows the company to sell the product throughout the European Economic Area.
The company intends to file for US Food and Drug Administration 510(k) clearance for CerMap in the near future.
